Health conscious consumers are craving mushrooms.
So much so they could help create a $50 billion market over the next seven years, says Grand View Research. In fact, as the analysts note, “Mushrooms are considered a superfood owing to their nutritional contents, such as selenium, vitamin D, glutathione, and ergothioneine. These nutrients help mitigate oxidative stress and prevent or decrease the risk of chronic conditions, such as cancer, heart disease, and dementia.”
Demand is creating a sizable catalyst for companies such as NeonMind Biosciences Inc. (CSE:NEON)(OTC:NMDBF), United Natural Foods Inc. (NASDAQ:UNFI), Starbucks Corporation (NASDAQ:SBUX), HAVN Life Sciences (CSE:HAVN)(OTC:HAVLF), and NEXE Innovations Inc. (TSXV:NEXE)(OTC:NEXNF).
In addition, according to The Food Institute, “Supplements, extracts, and protein powders from mushrooms, including chaga, lion’s mane, reishi, and shiitake continue to grow in popularity. Functional beverage offerings that incorporate these supplements, such as mushroom coffee, are also expanding.”